Drug firm Zydus Cadila on Thursday said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest pain.
The drug firm has also received final approval from US health regulator for Desonide Cream, used to treat a variety of skin conditions like eczema, dermatitis, allergies and rash, the company said.
The drug is used to prevent attacks of chest pain. lt expands blood vessels, making it easier for blood to flow through them and easier for the heart to pump.
It will be manufactured at the Group’s formulations manufacturing facility at Baddi, Himachal Pradesh.
The group also received the final approval for Desonide Cream (US RLD – Desonide Cream), 0.05%, the BSE filing said.